Summary: Micronization is a particle engineering technique that reduces the size of solid particles to the sub-micron or micron range, typically 1-10 microns in diameter. This reduction in particle size can improve the solubility, dissolution rate, and bioavailability of the active pharmaceutical ingredient (API) in the final drug product. The smaller particle size also leads to improved flow properties and handling, which can make the API easier to manufacture and process. During this webinar, speakers will discuss how with the right combination of technology and expertise, micronization can help to overcome many of the challenges faced by small molecule drugs and address the challenges and solutions to scale, yield and cost of goods for API particle engineering from formulation development through to commercial supply.
Achieving Desired Particle Size and Yield Through Efficient Micronization